| Literature DB >> 26788204 |
Yuichi Ohnishi1, Masahiro Watanabe1, Tomoko Fujii1, Noriko Sunada1, Hitoshi Yoshimoto1, Hirohito Kubo1, Masahiro Wato2, Kenji Kakudo1.
Abstract
Amelanotic malignant melanoma (AMM) is rare in the oral region. The present study examined the clinical features of this tumor in an attempt to establish diagnostic criteria. The expression of three melanocytic differentiation markers, HMB-45, S-100 and Melan-A, was also measured in primary oral AMMs in order to determine whether the markers could be used to diagnose primary oral AMMs and to find out which marker was the most sensitive. It may be particularly difficult to correctly diagnose AMM that lacks a radial growth phase without immunohistochemical assistance. In the present study, mixtures of polygonal and spindle cells at different ratios were observed in the tumors with and without a radial growth phase. Immunohistochemistry was used to examine the HMB-45, S-100 and Melan-A expression in the formalin-fixed paraffin-embedded specimens of primary oral AMMs. Comparison of staining intensities (SIs) and labeling indices (LIs) of the markers was also performed. The immunostaining results revealed that the SI of Melan-A was significantly higher than that of S-100 (P=0.0011). HMB-45, S-100 and Melan-A also exhibited high positive rates and LIs in AMMs and, therefore, may be good markers for the immunohistochemical diagnosis of primary oral AMMs. Furthermore, Melan-A may be a more sensitive marker than S-100 and HMB-45, as it has a higher SI.Entities:
Keywords: HMB-45; Melan-A; S-100; amelanotic malignant melanoma; immunohistochemistry; oral
Year: 2015 PMID: 26788204 PMCID: PMC4665211 DOI: 10.3892/ol.2015.3819
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967